Lakeland Industries (NASDAQ:LAKE – Free Report) had its target price decreased by DA Davidson from $14.00 to $10.00 in a report issued on Wednesday morning,Benzinga reports. DA Davidson currently has a neutral rating on the medical instruments supplier’s stock.
A number of other analysts also recently issued reports on the stock. Lake Street Capital dropped their price target on shares of Lakeland Industries from $19.00 to $16.00 and set a “buy” rating on the stock in a report on Thursday, April 2nd. Wall Street Zen downgraded shares of Lakeland Industries from a “hold” rating to a “strong sell” rating in a report on Saturday, December 13th. Zacks Research raised shares of Lakeland Industries from a “strong sell” rating to a “hold” rating in a report on Monday, February 9th. Roth Mkm dropped their price objective on shares of Lakeland Industries from $27.00 to $19.00 and set a “buy” rating on the stock in a report on Wednesday, December 10th. Finally, UBS Group set a $14.00 price objective on shares of Lakeland Industries in a report on Wednesday, December 10th. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Lakeland Industries currently has an average rating of “Hold” and a consensus price target of $14.75.
Check Out Our Latest Analysis on Lakeland Industries
Lakeland Industries Stock Performance
Hedge Funds Weigh In On Lakeland Industries
Several large investors have recently added to or reduced their stakes in the company. BNP Paribas Financial Markets lifted its holdings in Lakeland Industries by 87.8% during the third quarter. BNP Paribas Financial Markets now owns 1,795 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 839 shares in the last quarter. First Trust Advisors LP lifted its holdings in Lakeland Industries by 4.2% during the second quarter. First Trust Advisors LP now owns 28,554 shares of the medical instruments supplier’s stock valued at $389,000 after purchasing an additional 1,149 shares in the last quarter. Rhumbline Advisers lifted its holdings in Lakeland Industries by 16.0% during the third quarter. Rhumbline Advisers now owns 13,415 shares of the medical instruments supplier’s stock valued at $199,000 after purchasing an additional 1,853 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in Lakeland Industries by 35.5% during the fourth quarter. Wells Fargo & Company MN now owns 9,514 shares of the medical instruments supplier’s stock valued at $84,000 after purchasing an additional 2,492 shares in the last quarter. Finally, American Century Companies Inc. lifted its holdings in Lakeland Industries by 20.9% during the second quarter. American Century Companies Inc. now owns 15,762 shares of the medical instruments supplier’s stock valued at $215,000 after purchasing an additional 2,722 shares in the last quarter. Hedge funds and other institutional investors own 71.69% of the company’s stock.
About Lakeland Industries
Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.
The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.
See Also
Receive News & Ratings for Lakeland Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeland Industries and related companies with MarketBeat.com's FREE daily email newsletter.
